| The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema P Mitchell, F Bandello, U Schmidt-Erfurth, GE Lang, P Massin, ... Ophthalmology 118 (4), 615-625, 2011 | 1759 | 2011 |
| Vascular endothelial growth factors and angiogenesis in eye disease AN Witmer, G Vrensen, CJF Van Noorden, RO Schlingemann Progress in retinal and eye research 22 (1), 1-29, 2003 | 1281 | 2003 |
| Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions I Klaassen, CJF Van Noorden, RO Schlingemann Progress in retinal and eye research 34, 19-48, 2013 | 752 | 2013 |
| Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner … HGT Blaauwgeers, GM Holtkamp, H Rutten, AN Witmer, P Koolwijk, ... The American journal of pathology 155 (2), 421-428, 1999 | 687 | 1999 |
| Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) U Schmidt-Erfurth, V Chong, A Loewenstein, M Larsen, E Souied, ... British Journal of Ophthalmology 98 (9), 1144-1167, 2014 | 623 | 2014 |
| Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus EH Sohn, HW van Dijk, C Jiao, PHB Kok, W Jeong, N Demirkaya, ... Proceedings of the National Academy of Sciences 113 (19), E2655-E2664, 2016 | 560 | 2016 |
| Consensus guidelines for the use and interpretation of angiogenesis assays P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Angiogenesis 21, 425-532, 2018 | 553 | 2018 |
| Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study U Schmidt-Erfurth, B Eldem, R Guymer, JF Korobelnik, RO Schlingemann, ... Ophthalmology 118 (5), 831-839, 2011 | 516 | 2011 |
| Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study FG Holz, W Amoaku, J Donate, RH Guymer, U Kellner, RO Schlingemann, ... Ophthalmology 118 (4), 663-671, 2011 | 496 | 2011 |
| Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus LN Broekhuizen, BA Lemkes, HL Mooij, MC Meuwese, H Verberne, ... Diabetologia 53, 2646-2655, 2010 | 459 | 2010 |
| Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy HW Van Dijk, PHB Kok, M Garvin, M Sonka, JH DeVries, RPJ Michels, ... Investigative ophthalmology & visual science 50 (7), 3404-3409, 2009 | 457 | 2009 |
| Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes HW Van Dijk, FD Verbraak, PHB Kok, MK Garvin, M Sonka, K Lee, ... Investigative ophthalmology & visual science 51 (7), 3660-3665, 2010 | 435 | 2010 |
| Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study U Schmidt-Erfurth, GE Lang, FG Holz, RO Schlingemann, P Lanzetta, ... Ophthalmology 121 (5), 1045-1053, 2014 | 427 | 2014 |
| Early neurodegeneration in the retina of type 2 diabetic patients HW Van Dijk, FD Verbraak, PHB Kok, M Stehouwer, MK Garvin, M Sonka, ... Investigative ophthalmology & visual science 53 (6), 2715-2719, 2012 | 421 | 2012 |
| What is orbital pseudotumor? I Mombaerts, R Goldschmeding, RO Schlingemann, L Koornneef Survey of ophthalmology 41 (1), 66-78, 1996 | 386 | 1996 |
| Role of growth factors and the wound healing response in age-related macular degeneration RO Schlingemann Graefe's archive for clinical and experimental ophthalmology 242, 91-101, 2004 | 375 | 2004 |
| Central serous chorioretinopathy: towards an evidence-based treatment guideline TJ Van Rijssen, EH Van Dijk, S Yzer, K Ohno-Matsui, JEE Keunen, ... Progress in retinal and eye research 73, 100770, 2019 | 346 | 2019 |
| Monoclonal antibody PAL-Ε specific for endothelium RO Schlingemann, GM Dingjan, J Blok, JJ Emeis, SO Warnaar, DJ Ruiter Lab Invest 52, 71-76, 1985 | 301 | 1985 |
| Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. RO Schlingemann, FJ Rietveld, F Kwaspen, PC Van de Kerkhof, ... The American journal of pathology 138 (6), 1335, 1991 | 287 | 1991 |
| Ki-67 detects a nuclear matrix-associated proliferation-related antigen. I. Intracellular localization during interphase R Verheijen, HJ Kuijpers, RO Schlingemann, AL Boehmer, R Van Driel, ... Journal of cell science 92 (1), 123-130, 1989 | 277 | 1989 |
